NIH-funded research R01 grant

Identifying protective antibodies against group A streptococcal infections

Official title: Protective antibody in streptococcal infection models

Funded at New York Medical College · NIH-10747980 · Data updated 2026-11-12

This study is looking at how certain antibodies can help protect against group A strep infections by finding out which parts of the bacteria trigger a strong immune response, and it’s for anyone interested in a potential new vaccine that could keep kids and adults safe from different strains of this infection.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York Medical College
NIH-funded
Lab location1 site (Valhalla, United States)
Project startDecember 2, 2022
Project endNovember 30, 2028
Funding year2024
Award (this year)$599,556
NIH project number5R01AI173565-02
Project IDNIH-10747980 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children who are at risk of GAS infections and adults who have developed protective antibodies.

Less likely to help

Patients who have already been vaccinated against GAS or those with existing GAS infections may not benefit from this research.

What this research studies

This research investigates how antibodies can prevent group A streptococcal (GAS) infections by identifying specific antigens that trigger protective immune responses. The study involves analyzing serum samples from children and adults to understand the presence of protective antibodies. By using immunodeficient mice, the researchers will test the effectiveness of these antibodies against low doses of GAS, aiming to develop a multicomponent vaccine that could provide broad protection against various GAS strains.

Why it matters

Potential benefit: If successful, this research could lead to the development of a vaccine that significantly reduces the incidence of group A streptococcal infections in children.

How similar studies have gone: Previous research has shown promise in developing vaccines targeting similar bacterial infections, indicating potential success for this approach.

Where this research is happening

  • New York Medical College
    Valhalla, United States
    Active

Researchers

  • Principal investigator: Bessen, Debra E — New York Medical College
  • Study coordinator: Bessen, Debra E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.